Antipsychotic Agents: all 1,683 studies that test it
Page 8 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychoticsCompletedNCT06200584Not applicable
- Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control TrialActive, not recruitingNCT06200181Phase 3
- Drug Interaction StudyCompletedNCT06194864Phase 1
- Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill ElderlyCompletedNCT06168773Phase 2/3
- Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast CancerTerminatedNCT06161792Phase 2
- Bioequivalence Study in Healthy Subjects by Using of Chlorpromazine HCl 100mg TabletsCompletedNCT06154434Phase 1
- Psychopharmacological Treatment of Emotional DistressWithdrawnNCT06133114Phase 4
- A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease PsychosisCompletedNCT06068465Phase 3
- A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's DisorderActive, not recruitingNCT06021522Phase 3
- Learning and Decision-makingCompletedNCT06014606Not applicable
- Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy SubjectsCompletedNCT05964647Phase 1
- An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive SymptomsWithdrawnNCT05956600Not applicable
- Dopamine and CognitionCompletedNCT05884671Not applicable
- Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac RepolarizationCompletedNCT05841160Phase 1
- A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.Status unknownNCT05822713Phase 3
- Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)CompletedNCT05804721Phase 1
- A Study of Olanzapine in Patients With Acute AgitationStatus unknownNCT05803642Phase 3
- Quetiapine as Prophylaxis for Delirium in CABGStatus unknownNCT05801289Not applicable
- Pimavanserin for Sleep in Parkinson DiseaseWithdrawnNCT05796167Early Phase 1
- Quetiapine in Prevention of DeliriumCompletedNCT05793632Phase 2
- An Exploratory Analysis of Immune and Inflammatory Response Associated With ClozapineTerminatedNCT05741502Phase 4
- Electrophysiological Effects of Potential QT Prolonging DrugsCompletedNCT05716854Phase 1
- Does Psilocybin Require Psychedelic Effects to Treat Depression?CompletedNCT05710237Phase 2
- Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the ProstateWithdrawnNCT05647447Early Phase 1
- Pilot of Osanetant to Reduce Testosterone in Men With Adenocarcinoma of the ProstateTerminatedNCT05607342Early Phase 1
- Study of the Breast Milk Pharmacokinetics of Olanzapine and SamidorphanCompletedNCT05547100Phase 1
- Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric PatientsCompletedNCT05546359Phase 2/3
- Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting ConditionCompletedNCT05532254Phase 1
- RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)CompletedNCT05531591Phase 4
- Treatment for Post Acute COVID-19 SyndromeStatus unknownNCT05507372Not applicable
- Electrical Brain Stimulation and Pharmacological Treatments in Autism Spectrum DisorderCompletedNCT05491720Phase 1
- Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASDCompletedNCT05439616Phase 3
- Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon CancerWithdrawnNCT05433402Phase 1/2
- Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced CancerWithdrawnNCT05403580Phase 3
- Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac SurgeryTerminatedNCT05401058Not applicable
- Cariprazine Versus Placebo for Social Anxiety DisorderCompletedNCT05384483Phase 4
- Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU)Status unknownNCT05351736Phase 4
- Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and AdolescentsStatus unknownNCT05346731Phase 3
- A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease PsychosisWithdrawnNCT05344365Phase 2
- Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and TransportCompletedNCT05334108Phase 1
- The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of SchizophreniaCompletedNCT05322031Phase 4
- Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT05321602Phase 1
- Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep ApneaCompletedNCT05303935Phase 2
- Haloperidol and Dexamethasone Towards Postoperative Nausea and Pain in Adult After LaparoscopyCompletedNCT05246631Phase 4
- Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular CancerStatus unknownNCT05244577Phase 3
- Droperidol on Prevention of Cannabis Hyperemesis SyndromeStatus unknownNCT05244460Phase 3
- Olanzapine Anorexia CachexiaCompletedNCT05243251Phase 3
- Sleep Disorders in Chronic Kidney Disease PatientsStatus unknownNCT05240261Phase 1
- The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From OlanzapineTerminatedNCT05213143Phase 4
- The Role of Dopamine, Reward Learning and Prefrontal Activity in Expectation-induced Mood EnhancementCompletedNCT05208294Not applicable
- The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCsStatus unknownNCT05202275Phase 2
- Chlorpromazine and Standard of Care in GlioblastomaCompletedNCT05190315Phase 1
- Olanzapine in OUD PatientsWithdrawnNCT05179772Phase 2
- Comparative Bioavailability of Risperidone.CompletedNCT05179525Phase 1
- Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With SchizophreniaStatus unknownNCT05168007Phase 3
- Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.CompletedNCT05123976Phase 1
- Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic HysterectomyCompletedNCT05103410Phase 4
- Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse ControlStatus unknownNCT05098353Not applicable
- Cariprazine for Comorbid Cocaine and Opioid Use DisorderCompletedNCT05063201Phase 2
- Dopamine D3 Receptor Occupancy in Bipolar DepressionWithdrawnNCT05060549Phase 4
- A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in SchizophreniaCompletedNCT05039489Not applicable
- The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With SchizophreniaCompletedNCT05011669Phase 4
- Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I DisorderCompletedNCT04987658Phase 1
- Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy VolunteersCompletedNCT04969211Phase 1
- A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs AloneWithdrawnNCT04965272Phase 2
- The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum DepressionActive, not recruitingNCT04950868Phase 1
- A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare SettingsCompletedNCT04940039Phase 4
- Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer PatientsActive, not recruitingNCT04939090Phase 3
- Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active MetaboliteCompletedNCT04902105Phase 1
- Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia PatientsCompletedNCT04898270Phase 4
- Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male SubjectsCompletedNCT04881955Phase 1
- PK Study of IV and Oral Amisulpride in Subjects With Severe Renal ImpairmentCompletedNCT04849650Phase 1
- Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18CompletedNCT04849026Phase 1
- Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity DisorderStatus unknownNCT04843423Phase 4
- HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled TrialCompletedNCT04833023Phase 3
- Efficacy and Safety of Peropirone Hydrochloride Tablets in the Treatment of Adolescent Bipolar Disorder DepressionStatus unknownNCT04826510Phase 4
- Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of ConceptWithdrawnNCT04809116Phase 4
- Pimavanserin Treatment in TSCompletedNCT04794413Early Phase 1
- Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy VolunteersCompletedNCT04776499Phase 1
- Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar PatientsTerminatedNCT04771299Phase 3
- Clinical Efficacy and Change of Life Quality Through Using the Comprehensive Behavioral Intervention Treatment for TicsWithdrawnNCT04765085Not applicable
- Haloperidol for the Treatment of Nausea and Vomiting in the EDCompletedNCT04764344Phase 4
- Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate TreatmentCompletedNCT04754750Phase 1/2
- Comparing Haloperidol and Olanzapine in Treating Terminal DeliriumStatus unknownNCT04750395Phase 2
- Olanzapine for the Prevention of Postoperative Nausea and VomitingCompletedNCT04718727Phase 1/2
- A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of SchizophreniaCompletedNCT04712734Phase 1
- Psychobiological Mechanisms Underlying Chronic PainCompletedNCT04674670Not applicable
- Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast CancerCompletedNCT04669132Phase 2
- Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion SyndromeTerminatedNCT04639960Not applicable
- Reducing the Abuse Liability of Prescription OpioidsCompletedNCT04587115Early Phase 1
- The Effect of Antiemetics on Bowel Preparation Before ColonoscopyStatus unknownNCT04583111Phase 4
- Monitoring of Arrhythmias in Patients Treated With AntipsychoticsStatus unknownNCT04575103Not applicable
- Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia PatientsCompletedNCT04572685Phase 1
- Study on the Gut Microbial Mechanism of Negative Symptoms of SchizophreniaStatus unknownNCT04533724Early Phase 1
- Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant PsychosisActive, not recruitingNCT04529226Phase 2
- SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant SchizophreniaStatus unknownNCT04528095Phase 3
- Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic SyndromeSuspendedNCT04518319Phase 2
- Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated DeliriumWithdrawnNCT04513314Phase 4
- Evaluation of the Safety and Efficacy of N-desmethylclobazam in Patients With Peripheral Neuropathic PainSuspendedNCT04480164Phase 2
- Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model BuildingStatus unknownNCT04446234Phase 4